1. Twenty-Year Follow-Up of a Controlled Trial Comparing a Combination of Methotrexate Plus Cyclosporine with Cyclosporine Alone for Prophylaxis of Graft-versus-Host Disease in Patients Administered HLA-Identical Marrow Grafts for Leukemia 
Mohamed L. Sorror, MD, Wendy Leisenring, ScD, H. Joachim Deeg, MD, Paul J. Martin, MD, Rainer Storb, MD 
Biology of Blood and Marrow Transplantation 
Volume 11, Issue 10, Pages (October 2005)
DOI: /j.bbmt
Copyright © 2005 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
Kaplan-Meier product-limit estimates of overall survival among (A) CML patients and (B) AML patients, and (C) prevalence [2] of chronic GVHD in CML and AML patients, as stratified by the immunosuppressive regimen used: methotrexate/cyclosporine versus cyclosporine alone. CR indicates complete remission; CSP, cyclosporine; MTX, methotrexate.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2005 American Society for Blood and Marrow Transplantation Terms and Conditions